[The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
D000328:Adult; D000368:Aged; D002219:Carbamates / Q000627:therapeutic use*; D002994:Clofibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D002219:Carbamates; D004338:Drug Combinations; D011727:Pyridinolcarbamate; D002994:Clofibrate
L'associazione piridinolcarbamato e clofibrato nel trattamento di diabetici vasculopatici